We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

January 21, 2021

HealthXL/BrightInsight Digital Health C-Suite Series at J.P. Morgan

Commentary
HealthXL Research Team
&

As 2021 kicked off with the first-ever virtual J.P. Morgan, HealthXL collaborated with BrightInsight to bring together global leaders from across healthcare, medtech and life sciences to a Digital Health C-Suite meeting series. No long flights, no jet lags, no overpriced hotel rooms and coffees, but the same great minds to connect and brainstorm with. Over three days, we dove into hot topics in Digital Health. Here are our key takeaways!

Session 1: What can Biopharma Learn from Automotive, Retail and Banking’s Digital Journey?

These industries are lightyears ahead of Biopharma in their digital transformation. Who better to bring together for valuable insights on challenges overcome than leaders with experience from Amazon, MGM, Venmo and Volvo? Atif Rafiq, President, Commercial & Growth, MGM Resorts and Former Chief Digital Officer, Volvo, and Amit Jhawar, Former CEO, Venmo and Venture Partner, Accel led the conversation. 

What we shared:

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Session 2: What Medtech 3.0 Will Look Like as We Enter the Next Phase of Digitization

If Medtech’s digitization journey is a marathon, we’ve only just passed the first mile-marker. Medtech is finally evolving past traditional medical devices (think pacemakers) to connected devices that collect and share data.. So, what can Medtech do to activate this data to achieve meaningful outcomes?  Scott Huennekens, Medical Device CEO, Entrepreneur, Chairman, Board Member and Mick Farrell CEO, ResMed led the conversation.

What we shared:

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Session 3: How to Build a Strategic Digital Health Function within Biopharma

Biopharma is dabbling with technology and they need the right leadership and teams to really build and grow these functions that have not been their bread and butter to date. There is also a realization that investing heavily in only R&D is showing diminishing returns. So what steps can Biopharma take to build a strategic digital health function amongst all this change? Kal Patel, MD, CEO & Co-Founder, BrightInsight was joined by Karan Arora, Chief Commercial Digital Officer, Global Vice President, AstraZeneca and Francesca Wuttke, Chief Digital Officer, Almirall to led the conversation.

What we shared:

Want to join our community? We’d love to hear from you

 

About HealthXL and BrightInsight:

BrightInsight accelerates the speed at which biopharma and medtech companies can build and commercialise regulated digital health solutions through its regulated digital health platform.

HealthXL connects global leaders on common digital health challenges.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

Prescription DTx - the future of DTx

1st March @ 11:00am EDT

Join our Digital Health Meeting focused on Prescription DTx- the future of DTx. This is a great opportunity to listen to your peers and thought leaders in the industry while also getting involved in the discussion. Apply promptly to avoid disappointment.

Featuring
Brian Dolan
Brian Dolan
Founder/Lead Writer, Exits & Outcomes
Shwen Gwee
Shwen Gwee
VP and Head of Global Digital Strategy at Bristol Myers Squibb
Featuring
Brian Dolan
Brian Dolan
Founder/Lead Writer, Exits & Outcomes
Shwen Gwee
Shwen Gwee
VP and Head of Global Digital Strategy at Bristol Myers Squibb
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

The Power of Real-World Evidence in DTx-Pharma partnerships

3rd March @ 11:00 am EDT

Join our Digital Health Meeting as we discuss the power of RWE in DTx-Pharma partnerships. This is a great opportunity to connect with new people and listen to valuable insights from thought leaders in the industry. Apply promptly to avoid missing out.

Featuring
Aahuti Rai
Aahuti Rai
Chief Strategy & Growth Officer at Ampersand Health
Philip Russmeyer
Philip Russmeyer
Founder & CEO, FITFILE
Featuring
Aahuti Rai
Aahuti Rai
Chief Strategy & Growth Officer at Ampersand Health
Philip Russmeyer
Philip Russmeyer
Founder & CEO, FITFILE
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

DTx- Overview of the market and deals

8th March @ 10.30am EDT

Join our Digital Health Meeting as we discuss the DTx market and also the most remarkable investments and partnerships in the DTx industry in recent times. Listen, engage and enjoy.

Featuring
Dr Uzma Choudry
Dr Uzma Choudry
Venture Capital Investor, Octopus Ventures
Elan Tye
Elan Tye
Principal, JAZZ Venture Partners
Featuring
Dr Uzma Choudry
Dr Uzma Choudry
Venture Capital Investor, Octopus Ventures
Elan Tye
Elan Tye
Principal, JAZZ Venture Partners
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

How should we measure efficacy and safety of DTx products?

15th March @ 11:00am EDT

Join us as we discuss how efficacy and safety should be measured in DTx products. Apply now to interact with your peers and gain insight from thought leaders in the industry.

Featuring
Jessica Shull
Jessica Shull
European Lead, Digital Therapeutics Alliance
Jin Lee
Jin Lee
Director of Digital Health Product, Astellas
Featuring
Jessica Shull
Jessica Shull
European Lead, Digital Therapeutics Alliance
Jin Lee
Jin Lee
Director of Digital Health Product, Astellas

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery

Digital Health for Older Adults - Informal Caregivers

1st March 12:00pm EDT

Join our Digital Health Meeting as we discuss the unique opportunity for digital health companies both to support informal caregivers in the elderly healthcare management and to improve caregivers' mental health and wellness. Great opportunity to connect with peers and meet new people.

Featuring
Kerry Burnright
Kerry Burnright
Chief Gerontologist at GrandPad
Brian Kaskie
Brian Kaskie
Associate Professor, University of Iowa
Featuring
Kerry Burnright
Kerry Burnright
Chief Gerontologist at GrandPad
Brian Kaskie
Brian Kaskie
Associate Professor, University of Iowa
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

Prescription DTx - the future of DTx

1st March @ 11:00am EDT

Join our Digital Health Meeting focused on Prescription DTx- the future of DTx. This is a great opportunity to listen to your peers and thought leaders in the industry while also getting involved in the discussion. Apply promptly to avoid disappointment.

Featuring
Brian Dolan
Brian Dolan
Founder/Lead Writer, Exits & Outcomes
Shwen Gwee
Shwen Gwee
VP and Head of Global Digital Strategy at Bristol Myers Squibb
Featuring
Brian Dolan
Brian Dolan
Founder/Lead Writer, Exits & Outcomes
Shwen Gwee
Shwen Gwee
VP and Head of Global Digital Strategy at Bristol Myers Squibb
Clinician and Patient Engagement & Support
Clinician and Patient Engagement & Support
Clinician and Patient Engagement & Support
Clinician and Patient Engagement & Support

Conversational patient engagement – voice and chatbots

2nd March @ 10:30am EDT

Join our Digital Health meeting focused on Conversational engagement led by Keith Grimes. Apply now to get involved in the discussion.

Featuring
Keith Grimes
Keith Grimes
Clinical Innovation Director / Clinical AI Director at Babylon Health and Founder of VR Doctors
Vanessa Lemarié
Vanessa Lemarié
SVP Life Sciences & Rare Diseases, Ada Health
Featuring
Keith Grimes
Keith Grimes
Clinical Innovation Director / Clinical AI Director at Babylon Health and Founder of VR Doctors
Vanessa Lemarié
Vanessa Lemarié
SVP Life Sciences & Rare Diseases, Ada Health
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

The Power of Real-World Evidence in DTx-Pharma partnerships

3rd March @ 11:00 am EDT

Join our Digital Health Meeting as we discuss the power of RWE in DTx-Pharma partnerships. This is a great opportunity to connect with new people and listen to valuable insights from thought leaders in the industry. Apply promptly to avoid missing out.

Featuring
Aahuti Rai
Aahuti Rai
Chief Strategy & Growth Officer at Ampersand Health
Philip Russmeyer
Philip Russmeyer
Founder & CEO, FITFILE
Featuring
Aahuti Rai
Aahuti Rai
Chief Strategy & Growth Officer at Ampersand Health
Philip Russmeyer
Philip Russmeyer
Founder & CEO, FITFILE

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.